Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through network marketing channels and a website. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
IPO Year:
Exchange: NASDAQ
Website: mannatech.com
4 - MANNATECH INC (0001056358) (Issuer)
Mannatech, Incorporated (NASDAQ: MTEX) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ:LVGN), Guided Therapeutics (OTC:GTHP), Aeterna Zentaris (NASDAQ:AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and drug development agreements, and he has advised c
Mannatech, Incorporated (NASDAQ: MTEX) reported that Alfredo (Al) Bala, announced his retirement as the company's CEO effective April 1, 2024. J. Stanley Fredrick, Chairman of the Board of Mannatech, Incorporated stated, "Al will continue to serve the company as an advisor focused on customer acquisition and sales growth. This transition enables Al to work more closely with our associates in the field which has always been his first love. In this new role, Al will also focus on field and leadership development, leveraging his 43 years of experience in direct sales at both the field and corporate level helping to create and develop programs dedicated to growing people and sales." Mr. Fredr
Mannatech, Incorporated (NASDAQ:MTEX) ("Mannatech"), a global health and wellness company committed to transforming lives to make a better world, announced that its shareholders passed all proposals put to a vote at Mannatech's annual shareholder meeting (the "Meeting") held Tuesday, June 6, 2023. Mannatech's Chairman of the Board, J. Stanley Fredrick, chaired the Meeting and David Johnson, Mannatech's Chief Financial Officer, spoke to the shareholders sharing the company's financial results for 2022 and the first quarter of 2023. There were 1,872,422 outstanding shares of Mannatech's common stock as of April 20, 2023 entitled to vote and 1,270,511 shares, or approximately 67.9% represe
Mannatech, Incorporated (NASDAQ:MTEX) ("Mannatech"), a global health and wellness company committed to transforming lives to make a better world, announced that its shareholders passed all proposals put to a vote at Mannatech's annual shareholder meeting (the "Meeting") held Tuesday, June 14, 2022. Mannatech's Chairman of the Board, J. Stanley Fredrick, chaired the Meeting and David Johnson, Mannatech's Chief Financial Officer, spoke to the shareholders sharing the company's financial results for 2021 and the first quarter of 2022. There were 1,949,716 outstanding shares of Mannatech's common stock as of April 14, 2022 entitled to vote and 1,295,936 shares, or approximately 66.5% represen
Mannatech, Incorporated (NASDAQ:MTEX) ("Mannatech"), a global health and wellness company committed to transforming lives to make a better world, announced that its shareholders passed all proposals put to a vote at Mannatech's annual shareholder meeting (the "Meeting") held Tuesday, June 15, 2021. Mannatech's Chairman of the Board, J. Stanley Fredrick, chaired the Meeting and David Johnson, Mannatech's Chief Financial Officer, spoke to the shareholders sharing the company's financial results for 2020 and the first quarter of 2021. There were 2,063,280 outstanding shares of Mannatech's common stock as of April 16, 2021 entitled to vote and 1,450,658 shares, or approximately 70.3% represen
4 - MANNATECH INC (0001056358) (Issuer)
4 - MANNATECH INC (0001056358) (Issuer)
4/A - MANNATECH INC (0001056358) (Issuer)
4 - MANNATECH INC (0001056358) (Issuer)
3 - MANNATECH INC (0001056358) (Issuer)
4 - MANNATECH INC (0001056358) (Issuer)
4 - MANNATECH INC (0001056358) (Issuer)
4 - MANNATECH INC (0001056358) (Issuer)
4 - MANNATECH INC (0001056358) (Issuer)
4 - MANNATECH INC (0001056358) (Issuer)
8-K - MANNATECH INC (0001056358) (Filer)
10-Q - MANNATECH INC (0001056358) (Filer)
8-K - MANNATECH INC (0001056358) (Filer)
8-K - MANNATECH INC (0001056358) (Filer)
8-K - MANNATECH INC (0001056358) (Filer)
10-Q - MANNATECH INC (0001056358) (Filer)
8-K - MANNATECH INC (0001056358) (Filer)
10-Q - MANNATECH INC (0001056358) (Filer)
8-K - MANNATECH INC (0001056358) (Filer)
ARS - MANNATECH INC (0001056358) (Filer)
Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2024. Third Quarter Highlights Net sales for the quarter ended September 30, 2024 were $31.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $0.9 million, or 2.5%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $0.4 million, or 1.2%, and unfavorable foreign exchange caused a $0.5 million decrease in GAAP net sales as compared to the same period in 2023. The decline in revenues was principally due to slowi
Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2024. Second Quarter Highlights Net sales for the quarter ended June 30, 2024 were $27.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $4.9 million, or 14.9%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $4.2 million, or 12.9%, and unfavorable foreign exchange caused a $0.7 million decrease in GAAP net sales as compared to the same period in 2023. The decline in revenues was principally due to supply
Q1 2024 EPS of $0.63 vs. $0.32 in Q1 2023 Mannatech, Incorporated (NASDAQ:MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2024. First Quarter Highlights Net sales for the quarter ended March 31, 2024 were $29.4 million, as compared to $34.1 million for the same period in 2023, a decrease of $4.7 million, or 13.8%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $3.9 million, or 11.3%, and unfavorable foreign exchange caused a $0.8 million decrease in GAAP net sales as compared to the same period in 2023. The decline in revenues was principal
Mannatech, Incorporated (NASDAQ:MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its fourth quarter and year ended December 31, 2023. Fourth Quarter Highlights Fourth quarter 2023 net sales were $32.7 million, a decrease of $1.6 million, or 4.7%, as compared to $34.3 million in the fourth quarter of 2022. Gross profit as a percentage of net sales improved to 75.4% as compared to 69.0% for the same period in 2022. Reduced supply chain shipping costs more than offset price increases in certain raw materials. Operating loss in the fourth quarter was $0.9 million, improved from an operating loss
Mannatech, Incorporated (NASDAQ:MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2023. Third Quarter End Results Third quarter net sales for 2023 were $32.6 million, a decrease of $2.9 million, or 8.3%, as compared to $35.5 million in the third quarter of 2022. Our net sales decreased 8.5% on a constant dollar basis (see Non-GAAP Measures, below) however, foreign exchange increased GAAP net sales by $0.1 million, mostly due to the strengthening of the Korean Won. Third quarter operating income for 2023 was $0.2 million as compared to operating income of $1.4 million for the th
Mannatech, Incorporated (NASDAQ:MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2023. Second Quarter End Results Second quarter net sales for 2023 were $32.6 million, a decrease of $2.4 million, or 6.8%, as compared to $35.0 million in the second quarter of 2022. Our net sales decreased 4.0% on a constant dollar basis (see Non-GAAP Measures, below) as foreign exchange decreased GAAP net sales by $1.0 million, mostly due to the decline of the Korean Won and Japanese Yen. Second quarter operating loss for 2023 was $1.0 million as compared to operating income of $0.9 million fo
Mannatech, Incorporated (NASDAQ:MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend of $0.20 per share of common stock, payable on Thursday, June 29, 2023, to shareholders of record at the close of business on Thursday, June 15, 2023. The dividend demonstrates a commitment to rewarding shareholders and encouraging long-term investment in Mannatech's common stock. Alfredo "Al" Bala, President and CEO of Mannatech, said, "Mannatech is fully committed to delivering value to our shareholders." About Mannatech Mannatech, Incorporated is committed to transforming lives through the
Mannatech, Incorporated (NASDAQ:MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its fourth quarter of 2022. Quarter End Results Fourth quarter net sales for 2022 were $34.3 million, a decrease of $5.2 million, or 13.2%, as compared to $39.5 million in the fourth quarter of 2021. During the fourth quarter, the company's net sales declined 5.1% on a Constant dollar basis (a Non-GAAP financial measure); unfavorable foreign exchange during the fourth quarter caused a decrease of $3.2 million in net sales as compared to the fourth quarter of 2021. The fourth quarter of 2022, tax provision was $3.4 millio
Mannatech, Incorporated (NASDAQ:MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend of $0.20 per share of common stock, payable on Thursday, March 30, 2023, to shareholders of record at the close of business on Thursday, March 16, 2023. The dividend demonstrates a commitment to rewarding shareholders and encouraging long-term investment in Mannatech's common stock. Alfredo "Al" Bala, President and CEO of Mannatech, said, "Mannatech is fully committed to delivering value to our shareholders." About Mannatech Mannatech, Incorporated is committed to transforming lives through the d
Mannatech, Incorporated (NASDAQ:MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend of $0.20 per share of common stock, payable on Wednesday, December 28, 2022, to shareholders of record at the close of business on Wednesday, December 14, 2022. The dividend demonstrates a commitment to rewarding shareholders and encouraging long-term investment in Mannatech's common stock. Alfredo "Al" Bala, President and CEO of Mannatech, said, "Mannatech is fully committed to delivering value to our shareholders." About Mannatech Mannatech, Incorporated is committed to transforming lives throu
SC 13G - MANNATECH INC (0001056358) (Subject)
SC 13G/A - MANNATECH INC (0001056358) (Subject)
SC 13G/A - MANNATECH INC (0001056358) (Subject)
SC 13G/A - MANNATECH INC (0001056358) (Subject)
Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2024. Third Quarter Highlights Net sales for the quarter ended September 30, 2024 were $31.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $0.9 million, or 2.5%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $0.4 million, or 1.2%, and unfavorable foreign exchange caused a $0.5 million decrease in GAAP net sales as compared to the same period in 2023. The decline in revenues was principally due to slowi
Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2024. Second Quarter Highlights Net sales for the quarter ended June 30, 2024 were $27.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $4.9 million, or 14.9%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $4.2 million, or 12.9%, and unfavorable foreign exchange caused a $0.7 million decrease in GAAP net sales as compared to the same period in 2023. The decline in revenues was principally due to supply
Mannatech, Incorporated (NASDAQ: MTEX) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ:LVGN), Guided Therapeutics (OTC:GTHP), Aeterna Zentaris (NASDAQ:AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and drug development agreements, and he has advised c
Q1 2024 EPS of $0.63 vs. $0.32 in Q1 2023 Mannatech, Incorporated (NASDAQ:MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2024. First Quarter Highlights Net sales for the quarter ended March 31, 2024 were $29.4 million, as compared to $34.1 million for the same period in 2023, a decrease of $4.7 million, or 13.8%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $3.9 million, or 11.3%, and unfavorable foreign exchange caused a $0.8 million decrease in GAAP net sales as compared to the same period in 2023. The decline in revenues was principal
Mannatech, Incorporated (NASDAQ:MTEX), a leading global health and wellness company committed to transforming lives through Glycan technology, is thrilled to announce a significant milestone in its expansion efforts. With a steadfast commitment to empowering individuals and communities through innovative health solutions, Mannatech is excited to announce its continued expansion into the ASEAN region, with the official launch into the Thailand market. This opening will bring Mannatech's global presence to 26 markets. ^ Existing and future Mannatech Associates eagerly anticipate the official launch in Thailand on June 17, 2024. During the soft opening, individuals will be able to register
Mannatech, Incorporated (NASDAQ:MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its fourth quarter and year ended December 31, 2023. Fourth Quarter Highlights Fourth quarter 2023 net sales were $32.7 million, a decrease of $1.6 million, or 4.7%, as compared to $34.3 million in the fourth quarter of 2022. Gross profit as a percentage of net sales improved to 75.4% as compared to 69.0% for the same period in 2022. Reduced supply chain shipping costs more than offset price increases in certain raw materials. Operating loss in the fourth quarter was $0.9 million, improved from an operating loss
Mannatech, Incorporated (NASDAQ: MTEX) reported that Alfredo (Al) Bala, announced his retirement as the company's CEO effective April 1, 2024. J. Stanley Fredrick, Chairman of the Board of Mannatech, Incorporated stated, "Al will continue to serve the company as an advisor focused on customer acquisition and sales growth. This transition enables Al to work more closely with our associates in the field which has always been his first love. In this new role, Al will also focus on field and leadership development, leveraging his 43 years of experience in direct sales at both the field and corporate level helping to create and develop programs dedicated to growing people and sales." Mr. Fredr
Mannatech, Incorporated (NASDAQ:MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2023. Third Quarter End Results Third quarter net sales for 2023 were $32.6 million, a decrease of $2.9 million, or 8.3%, as compared to $35.5 million in the third quarter of 2022. Our net sales decreased 8.5% on a constant dollar basis (see Non-GAAP Measures, below) however, foreign exchange increased GAAP net sales by $0.1 million, mostly due to the strengthening of the Korean Won. Third quarter operating income for 2023 was $0.2 million as compared to operating income of $1.4 million for the th
Mannatech, Incorporated (NASDAQ:MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2023. Second Quarter End Results Second quarter net sales for 2023 were $32.6 million, a decrease of $2.4 million, or 6.8%, as compared to $35.0 million in the second quarter of 2022. Our net sales decreased 4.0% on a constant dollar basis (see Non-GAAP Measures, below) as foreign exchange decreased GAAP net sales by $1.0 million, mostly due to the decline of the Korean Won and Japanese Yen. Second quarter operating loss for 2023 was $1.0 million as compared to operating income of $0.9 million fo
Mannatech, Incorporated (NASDAQ:MTEX) ("Mannatech"), a global health and wellness company committed to transforming lives to make a better world, announced that its shareholders passed all proposals put to a vote at Mannatech's annual shareholder meeting (the "Meeting") held Tuesday, June 6, 2023. Mannatech's Chairman of the Board, J. Stanley Fredrick, chaired the Meeting and David Johnson, Mannatech's Chief Financial Officer, spoke to the shareholders sharing the company's financial results for 2022 and the first quarter of 2023. There were 1,872,422 outstanding shares of Mannatech's common stock as of April 20, 2023 entitled to vote and 1,270,511 shares, or approximately 67.9% represe
Mannatech (NASDAQ:MTEX) reported quarterly earnings of $0.63 per share. This is a 96.88 percent increase over earnings of $0.32 per share from the same period last year. The company reported $29.39 million in sales this quarter. This is a 13.84 percent decrease over sales of $34.11 million the same period last year.
Mannatech (NASDAQ:MTEX) reported quarterly losses of $(0.94) per share. This is a 75.13 percent increase over losses of $(3.78) per share from the same period last year. The company reported $32.69 million in sales this quarter. This is a 4.78 percent decrease over sales of $34.34 million the same period last year.
Mannatech, Incorporated (NASDAQ: MTEX) reported that Alfredo (Al) Bala, announced his retirement as the company's CEO effective April 1, 2024. J. Stanley Fredrick, Chairman of the Board of Mannatech. Mr. Fredrick further stated, "Coinciding with Al's retirement, I am pleased to announce the promotion of Landen Fredrick to the position of President and CEO. Landen's succession to the CEO position was made possible by Al's mentorship over the past few years where Landen served as President and Chief Operating Officer. As CEO, Landen will oversee the senior executive team and the team of general managers over our international markets, driving operational excellence, and executing the company'
Tuesday saw 132 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Corning (NYSE:GLW) was the largest, in terms of market cap, to set a new 52-week low. Wheeler Real Estate IT (NASDAQ:WHLR) was the smallest company when considering market cap to set a new 52-week low. Fortress Biotech (NASDAQ:FBIO) saw the largest move of the companies, as shares plummetted 1350.03% to hit a new 52-week low. Insulet (NASDAQ:PODD)'s stock made the biggest bounce back, actually moving up 0.0% shortly after hitting a new 52-week low. Here are all the stocks that set new 52-week lows on Tuesday: Corning (NYSE:GLW) shares were up 0.2% for the day, having made a 52-week lo
Mannatech (NASDAQ:MTEX) reported quarterly losses of $(0.59) per share. This is a 273.53 percent decrease over earnings of $0.34 per share from the same period last year. The company reported $32.60 million in sales this quarter. This is a 6.79 percent decrease over sales of $34.98 million the same period last year.
Mannatech (NASDAQ:MTEX) reported quarterly earnings of $0.32 per share. This is a 433.33 percent increase over earnings of $0.06 per share from the same period last year. The company reported $34.11 million in sales this quarter. This is a 5.34 percent increase over sales of $32.38 million the same period last year.
Gainers Barnes & Noble Education, Inc. (NYSE:BNED) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales. Molecular Templates, Inc. (NASDAQ:MTEM) rose 29.7% to $0.61. Molecular Templates received FDA clearance to proceed for clinical testing of its novel MT-8421 ETB program. Jeffs' Brands Ltd (NASDAQ:JFBR) gained 23% to $1.7110. Jeffs' Brands recently entered into a definitive agreement to acquire the entire share capital of Fort Products Ltd for $1.92 million. PLAYSTUDIOS, Inc. (NASDAQ:MYPS) gained 20.5% to $4.1814 after reporting upbeat quarterly results. Unicycive Therapeutics, Inc. (NASDAQ:UNCY) shares rose 19.7% to $2.47 after jumping 27% on Thursday.